These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26006332)

  • 1. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
    Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic modeling of gut hormone peptide YY
    Shao J; Chen MJ; Kuehl PJ; Hochhaus G
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1101-1110. PubMed ID: 31039626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
    Sloth B; Davidsen L; Holst JJ; Flint A; Astrup A
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E604-9. PubMed ID: 17566112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary delivery of peptide YY for food intake suppression and reduced body weight gain in rats.
    Nadkarni PP; Costanzo RM; Sakagami M
    Diabetes Obes Metab; 2011 May; 13(5):408-17. PubMed ID: 21226821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY and appetite control.
    McGowan BM; Bloom SR
    Curr Opin Pharmacol; 2004 Dec; 4(6):583-8. PubMed ID: 15525548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.
    Hou A; Li L; Huang Y; Singh V; Zhu C; Pan X; Quan G; Wu C
    Drug Deliv Transl Res; 2018 Jun; 8(3):693-701. PubMed ID: 29600480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits.
    Sileno AP; Brandt GC; Spann BM; Quay SC
    Int J Obes (Lond); 2006 Jan; 30(1):68-72. PubMed ID: 16172618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
    Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
    Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections.
    Vandenheuvel D; Singh A; Vandersteegen K; Klumpp J; Lavigne R; Van den Mooter G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):578-82. PubMed ID: 23353012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits.
    Sullivan BP; El-Gendy N; Kuehl C; Berkland C
    Mol Pharm; 2015 Aug; 12(8):2665-74. PubMed ID: 25915095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation.
    He J; Zhang G; Zhang Q; Chen J; Zhang Y; An X; Wang P; Xie S; Fang F; Zheng J; Tang Y; Zhu J; Yu Y; Chen X; Lu Y
    J Pharm Pharmacol; 2019 Feb; 71(2):176-184. PubMed ID: 30324757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity research. New data on appetite-suppressing peptide challenge critics.
    Gura T
    Science; 2004 Nov; 306(5701):1453-4. PubMed ID: 15567820
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.
    Seto Y; Suzuki G; Leung SS; Chan HK; Onoue S
    Pharm Res; 2016 Jun; 33(6):1447-55. PubMed ID: 26975360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin B12 conjugation of peptide-YY(3-36) decreases food intake compared to native peptide-YY(3-36) upon subcutaneous administration in male rats.
    Henry KE; Elfers CT; Burke RM; Chepurny OG; Holz GG; Blevins JE; Roth CL; Doyle RP
    Endocrinology; 2015 May; 156(5):1739-49. PubMed ID: 25658456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology: does gut hormone PYY3-36 decrease food intake in rodents?
    Tschöp M; Castañeda TR; Joost HG; Thöne-Reineke C; Ortmann S; Klaus S; Hagan MM; Chandler PC; Oswald KD; Benoit SC; Seeley RJ; Kinzig KP; Moran TH; Beck-sickinger AG; Koglin N; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Schindler M; Arndt K; Rudolf K; Mark M; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Craney S; Flora D; Smiley D; Heiman ML
    Nature; 2004 Jul; 430(6996):1 p following 165; discussion 2 p following 165. PubMed ID: 15243972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.
    Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D
    Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.